This company seems to have been delisted
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Reason: Filed for chapter 7 bankruptcy
Last recorded trade on: December 27, 2023
Source: https://www.genomeweb.com/business-news/biocept-files-chapter-7-bankruptcy
Biocept
BIOC
$0.43
Share price
0.00%
Change (1 day)
-95.74%
Change (1 year)
Categories
P/S ratio for Biocept (BIOC)
P/S ratio on December 27, 2023 (TTM) : -0.3324
According to Biocept 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.94. At the end of 2023 the company had a P/S ratio of N/A.
P/S ratio history for Biocept from 2014 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | N/A | -100% |
| 2022 | 0.3496 | -64.87% |
| 2021 | 0.9954 | -54.04% |
| 2020 | 2.17 | -23.51% |
| 2019 | 2.83 | 131.16% |
| 2018 | 1.22 | -74.57% |
| 2017 | 4.82 | 14.47% |
| 2016 | 4.21 | -90.55% |
| 2015 | 44.5 | -46.19% |
| 2014 | 82.7 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 | 3.07 | -1,025.13% | 🇺🇸 USA |
 | 1.06 | -419.12% | 🇺🇸 USA |
 | 5.89 | -1,872.34% | 🇺🇸 USA |